Compare Funds
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
cancel

UTI Healthcare Fund Direct Growth

Equity
Sectoral/Thematic
2.0 star
INVEST NOW
cancel

SBI Healthcare Opportunities Fund Direct Plan Growth

Equity
Sectoral/Thematic
3.0 star
INVEST NOW
add_circle_outline

Add a fund

UTI Healthcare Fund Direct Growth

(63.5%)

SBI Healthcare Opportunities Fund Direct Plan Growth

(61.8%)
1Y
3Y
5Y
Fund Details
keyboard_arrow_up
RiskHighHigh-
Min SIP Amount₹500₹500-
Expense Ratio1.85%1.15%-
NAV₹137.9 (29-Sep-2020)₹192.0 (29-Sep-2020)-
Fund Started01-Jan-201301-Jan-2013-
Fund Size₹563Cr₹1,361Cr-
Returns
keyboard_arrow_up
1Y
63.5%
61.8%
-
3Y
17.2%
14.6%
-
5Y
6.5%
4.8%
-
Pros & Cons
keyboard_arrow_up
Pros
Found nothing so far.
Found nothing so far.
-
Cons
1. Asset under management(AUM) is less than 500 Crs. Watch expense ratio when AUM is very low
2. Risk-adjusted returns are lower compared to the category
3. Higher expense ratio - 1.77%
4. 3Y Returns are lower than the category average returns
5. 5Y Returns are lower than the category average returns
1. Risk-adjusted returns are lower compared to the category
2. 3Y Returns are lower than the category average returns
3. 5Y Returns are lower than the category average returns
-

Holding Analysis

keyboard_arrow_up
Top 5
-
-
-
Top 20
-
-
-
P/E
-
-
-
P/B
-
-
-
Turn Over
-
-
-
Equity
-
-
-
Cash
-
-
-

Top Holdings

keyboard_arrow_up
Top 10 Holdings
Name
Assets
Sun Pharmaceutical Inds. Ltd.
11.9%
Dr. Reddy's Laboratories Ltd.
10.1%
Divi's Laboratories Ltd.
9.8%
Cipla Ltd.
6.5%
Ipca Laboratories Ltd.
6.3%
Aurobindo Pharma Ltd.
4.8%
Laurus Labs Ltd.
4.6%
Cadila Healthcare Ltd.
4.0%
Eris Lifesciences Ltd
4.0%
Biocon Ltd.
3.6%
Name
Assets
Sun Pharmaceutical Inds. Ltd.
9.6%
Lupin Ltd.
9.5%
Cipla Ltd.
9.4%
Aurobindo Pharma Ltd.
8.9%
Dr. Reddy's Laboratories Ltd.
8.8%
Divi's Laboratories Ltd.
8.1%
Strides Pharma Science Ltd.
4.4%
Narayana Hrudayalaya Ltd.
3.8%
Alkem Laboratories Ltd.
3.2%
Thyrocare Technologies Ltd.
3.0%
-
Fund Manager
keyboard_arrow_up
Name
V Srivatsa
Tanmaya Desai
-
Education

Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.

Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).

-

Experience

Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.

Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.

-

About Fund
keyboard_arrow_up
Description

UTI Mutual Fund started their mutual fund on 01/02/2003 and its managing total assets of ₹1,50,669 Cr. Its ranked at 6 as per total assets at end of 30th Sep 2017.

SBI Mutual Fund started their mutual fund on 29/06/1987 and its managing total assets of ₹1,88,455 Cr. Its ranked at 5 as per total assets at end of 30th Sep 2017.

-

Launch Date
01 Feb 2003
29 Jun 1987
-
Custodian
Stock Holding Corp. of India Ltd.
SBI SG Global Securities Services Pvt.Ltd.
-
Registrar & Transfer Agent
KFin Tech
Cams
-

Popular Comparisons

Motilal Oswal Multicap 35 Fund - Direct - Growth
17.8%
3Y Returns
VS
SBI Magnum Multi Cap Fund - Direct - Growth
16.3%
3Y Returns
Axis Bluechip Fund - Direct - Growth
17.4%
3Y Returns
VS
SBI Bluechip Fund - Direct - Growth
13.6%
3Y Returns
HDFC Small Cap Fund - Direct - Growth
22.9%
3Y Returns
VS
L&T Emerging Businesses Fund - Direct - Growth
22.4%
3Y Returns